Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.05 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 4 Parkinson's papers of 335 | 0.79 |
| pathways Reactome | 3 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 4926
Sealed predictions
- AKR1C2 in dopamine neurons, braak+0.84 (p 0.005) → +0.65 (p 0.060)receipt 4934
Swarm cases
receipt 4934: AKR1C2 in dopamine neurons, braak
- power
- full sample +0.79 (p 9.5e-5, n 18), 95% CI +0.51 to +0.92. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.82 (p 3.6e-5, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.83 (p 2.1e-5, n 18). not the mix.
- skeptic
- leave-one-out range +0.76 to +0.86, sign flips 0; without severely affected donors +0.79 (p 9.5e-5, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for AKR1C2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts